EUCTR2016-001019-19-BE进行中（未招募）1 期
A pilot trial of triheptanoin for the preventive treatment of migraine - TRIMIG
IEGE University Hospital0 个研究点目标入组 10 人开始时间: 2016年5月2日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •- Females aged 18-65 years old having an effective contraception, having undergone a bilateral salpingo-oophorectomy or being menopaused, willing and able to fill in the headache diary and to recognize their migraine attacks
- •- Diagnosis of migraine without aura (ICHD3beta 1.1) since at least 2 years
- •- 4-10 migraine days per month during the last 3 months
- •- No preventive anti-migraine therapy during the last month
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- > 4 tension-type headache episodes per month (ICHD-3beta 2.2 & 2.3)
- •- Medication overuse headache or other headache types (ICHD-3beta 8.2)
- •- Resistance to >3 previous preventive anti-migraine drug treatments
- •- Any serious medical or psychiatric condition
- •- Having a concurrent disease or condition, or laboratory abnormality that, in the view of the Investigator, places the subject at high risk of poor treatment compliance or of not completing the study, or would interfere with study participation or introduces additional safety concerns
研究者
相似试验
Unknown
早期 1 期
A Pilot Trial of Triheptanoin for the Preventive Treatment of MigraineMigraineNCT02784847University of Liege10
已完成
2 期
Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body DiseaseAdult Polyglucosan Body DiseaseGlycogen Brancher Enzyme DeficiencyGlycogen Storage Disease Type IVNCT00947960Baylor Research Institute23
已完成
2 期
An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency SyndromeGlucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)NCT02036853Adrian Lacy20
已完成
早期 1 期
Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type IGlycogen Storage Disease Type INCT03665636Areeg El-Gharbawy4
进行中（未招募）
1 期
see beelow/AMedDRA version: 20.0 Level: HLGT Classification code 10039911 Term: Seizures (incl subtypes) System Organ Class: 10029205 - Nervous system disordersEUCTR2014-003920-32-FRINSERM20